ALL vs LAB · P/E 4.9, $56.89B cap vs rev $174.4M
The Allstate Corporation (ALL) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. LAB currently screens at market cap $317.1M.
Not investment advice. Open the ALL and LAB stock pages for the full models.
Not investment advice.